TY  - GEN
AU  - Asleh,Karama
AU  - Lyck Carstensen,Stina
AU  - Tykjaer Jørgensen,Charlotte L
AU  - Burugu,Samantha
AU  - Gao,Dongxia
AU  - Won,Jennifer R
AU  - Jensen,Maj-Britt
AU  - Balslev,Eva
AU  - Laenkholm,Anne-Vibeke
AU  - Nielsen,Dorte L
AU  - Ejlertsen,Bent
AU  - Nielsen,Torsten O
TI  - Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial
SN  - 1097-0215
PY  - 2019///0806
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Clinical Trials, Phase III as Topic
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Gene Expression Profiling
KW  - methods
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Nestin
KW  - Phosphoric Monoester Hydrolases
KW  - Prognosis
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Retrospective Studies
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ijc.31969
ER  -